 | Up a level |
Cyrta, Joanna; Augspach, Anke; De Filippo, Maria Rosaria; Prandi, Davide; Thienger, Phillip; Benelli, Matteo; Cooley, Victoria; Bareja, Rohan; Wilkes, David; Chae, Sung-Suk; Cavaliere, Paola; Dephoure, Noah; Uldry, Anne-Christine; Braga Lagache, Sophie; Roma, Luca; Cohen, Sandra; Jaquet, Muriel; Brandt, Laura P.; Alshalalfa, Mohammed; Puca, Loredana; ... (2020). Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity. Nature Communications, 11(1), p. 5549. Springer Nature 10.1038/s41467-020-19328-1
Arriaga, Juan M.; Panja, Sukanya; Alshalalfa, Mohammed; Zhao, Junfei; Zou, Min; Giacobbe, Arianna; Madubata, Chioma J.; Kim, Jaime Yeji; Rodriguez, Antonio; Coleman, Ilsa; Virk, Renu K.; Hibshoosh, Hanina; Ertunc, Onur; Ozbek, Büşra; Fountain, Julia; Jeffrey Karnes, R.; Luo, Jun; Antonarakis, Emmanuel S.; Nelson, Peter S.; Feng, Felix Y.; ... (2020). A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance. Nature ancer, 1(11), pp. 1082-1096. Springer Nature 10.1038/s43018-020-00125-0
Batista da Costa, José; Gibb, Ewan A; Bivalacqua, Trinity J; Liu, Yang; Oo, Htoo Zarni; Miyamoto, David T; Alshalalfa, Mohammed; Davicioni, Elai; Wright, Jonathan; Dall'Era, Marc A; Douglas, James; Boormans, Joost L; Van der Heijden, Michiel S; Wu, Chin-Lee; van Rhijn, Bas W G; Gupta, Shilpa; Grivas, Petros; Mouw, Kent W; Murugan, Paari; Fazli, Ladan; ... (2019). Molecular Characterization of Neuroendocrine-like Bladder Cancer. Clinical cancer research, 25(13), pp. 3908-3920. American Association for Cancer Research 10.1158/1078-0432.CCR-18-3558
Zhao, Shuang G; Chang, S Laura; Erho, Nicholas; Yu, Menggang; Lehrer, Jonathan; Alshalalfa, Mohammed; Speers, Corey; Cooperberg, Matthew R; Kim, Won; Ryan, Charles J; Den, Robert B; Freedland, Stephen J; Posadas, Edwin; Sandler, Howard; Klein, Eric A; Black, Peter; Seiler, Roland; Tomlins, Scott A; Chinnaiyan, Arul M; Jenkins, Robert B; ... (2017). Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA oncology, 3(12), pp. 1663-1672. American Medical Association 10.1001/jamaoncol.2017.0751
Alshalalfa, Mohammed; Verhaegh, Gerald W; Gibb, Ewan A; Santiago-Jiménez, Maria; Erho, Nicholas; Jordan, Jennifer; Yousefi, Kasra; Lam, Lucia L C; Kolisnik, Tyler; Chelissery, Jijumon; Seiler, Roland; Ross, Ashley E; Karnes, R Jeffrey; Schaeffer, Edward M; Lotan, Tamara T; Den, Robert B; Freedland, Stephen J; Davicioni, Elai; Klein, Eric A and Schalken, Jack A (2017). Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients. OncoTarget, 8(31), pp. 50804-50813. Impact Journals LLC 10.18632/oncotarget.15133
